As shown, the ME180-G-CSF-derived tumor-bearing mice displayed markedly increased MDSC (CD11b+ Gr-1+ cells) frequencies in their bone marrow, blood, spleens, and tumors compared with the ME180-control-derived tumor-bearing mice (Fig. 2C). This evidence concerns the gene CSF3 and neoplasm.